RxDoctor Payments Data

Deborah Dzielski

Adult Health · Williamsville, NYNPI 1427192871

Payments from drug & device makers

$2,675in general payments, 2019–2025

Across 193 payments — averaging $13.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$1K
  • AbbVie$534
  • Nevro Corp.$201
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$181
  • Abbott$148
  • Pfizer$126
  • plus $436 from 12 others

What the payments were for

  • Food & beverage$2,675100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,675 in reported general payments places this provider in the 85th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York

Medicare billing

Part B allowed, 2024
$59,405
Medicare patients
172
Services billed
2,198

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl142$92,549
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen2,596$79,618
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen993$59,644
Oxycodone Hcl1,008$32,476
Xtampza ErOxycodone Myristate38$29,931
Oxymorphone Hcl ErOxymorphone Hcl43$28,303
NucyntaTapentadol Hcl24$23,050
Morphine Sulfate ErMorphine Sulfate541$19,126
Emgality PenGalcanezumab-Gnlm21$14,713
Lidocaine78$13,754
BelbucaBuprenorphine Hcl12$11,373
MovantikNaloxegol Oxalate25$10,654
Nucynta ErTapentadol Hcl12$7,512
Tramadol Hcl ErTramadol Hcl54$7,344
Fentanyl97$7,002

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta, Belbuca, Nucynta Er$1,049$71,86786 claims
Hikma Pharmaceuticals USAMorphine Sulfate, Buprenorphine Hcl$16$6,054124 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,828 adult health providers in New York.

Other adult health in Williamsville

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →